Today in World Hepatitis Day, which every July 28th brings the world together under a single theme to raise awareness of the global burden of viral hepatitis and to influence real change. Viral hepatitis...

Scientists developing promising new antibiotics in India, Ireland, France, Switzerland, the US and UK are to share up to US$17.6m to speed treatments for the world’s deadliest superbugs. A year since...

Pathogenic bacteria are rapidly developing resistance to the arsenal of microbial therapies – and driving researchers to identify families of therapeutics with new modes of action. Recently, those include...

A vaginal ring that researchers are hopeful will be approved as a method for preventing HIV in women was found to be safe and acceptable in teen girls, according to results of a study conducted in the...

The U.S. Food and Drug Administration today approved Vosevi to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis. Vosevi is a fixed-dose,...

The U.S. Food and Drug Administration today approved Nerlynx (neratinib) for the extended adjuvant treatment of early-stage, HER2-positive breast cancer. For patients with this type of cancer, Nerlynx...

The U.S. Food and Drug Administration (FDA) has granted Fast Track designation to VT-1598, a novel oral agent for the treatment of coccidioidomycosis, also known as Valley Fever, according to Viamet Pharmaceuticals...

Antibiotic resistance is a growing problem, especially among a type of bacteria that are classified as “Gram-negative.” These bacteria have two cell membranes, making it more difficult for...

U.S. Food and Drug Administration (FDA) last week approved the Psoriatic Arthritis (PsA) treatment, ORENCIA (abatacept) by Bristol-Myers Squibb Company. ORENCIA is approved and available in both...

On Friday, the World Health Organization (WHO) released alarming new data showing that of 77 countries surveyed across the world, more than 60% report resistance to the last-resort treatment for gonorrhea. On...